One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Compare complete versions: U.S. labeling uses 2-hour infusions, while UCSF uses 3-hour extended infusions. Nebraska separately lists an HD/PD interval different from the label. Do not select a dose from one version and an interval from another.
The columns omit exactly 5. All these institutional infusions last 3 hours; do not silently substitute the product-label infusion duration.
| CrCl, mL/min | Source-specific dose / instruction |
|---|---|
| >50 | 2.5 g every 8 hours |
| 31-50 | 1.25 g every 8 hours |
| 16-30 | 0.94 g every 12 hours |
| 6-15 | 0.94 g every 24 hours |
| <5 | 0.94 g every 48 hours |
| Dialysis setting / indication | Source-specific schedule |
|---|---|
| IHD | 0.94 g initially, then each evening |
| IHD alternative - minimal residual function and less severe infection | 0.94 g every 48 hours in the evening |
| CVVHD | 2.5 g every 8 hours |
Doses refer to the combined product and are infused IV over 3 hours. CrCl columns as published (>50 / 31-50 / 16-30 / 6-15 / <5 mL/min) correspond to 2.5 g every 8 hours / 1.25 g every 8 hours / 0.94 g every 12 hours / 0.94 g daily / 0.94 g every 48 hours.
The published columns omit exactly 5 mL/min; that boundary is not repaired by assumption.
IHD: 0.94 g initially, then each evening. For minimal residual kidney function and less severe infection, an alternative is 0.94 g every 48 hours in the evening. CVVHD: 2.5 g every 8 hours. All these institutional infusions last 3 hours; retain separately from product-label infusion instructions.
RDM30-006-ceftazidime-avibactam-1 · Source locator: UCSF - AVYCAZ extended-infusion protocol; renal/dosing sections and stated qualifiers
The website writes <5 rather than <=5. Exact-boundary ambiguity is retained.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=ceftazidime-avibactam&s1=RDM30-006-ceftazidime-avibactam&h1=4c596d50e43379bdad70fe165f49f16f593ba3f62edab390595a92d2be6a3399